Aethlon Medical (AEMD)

• Market cap: $4.11M
• 1 day: 12.86%
• 5 days: 42.34%
• 1 month: 23.44%
• 3 months: -48.03%
• 6 months: -66.02%
• Year to date: -75.31%
• 1 year: -61.56%
• 5 years: -98.69%
• 10 years: -99.98%
• Sector: Healthcare
• Industry: Medical Devices

About: Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.

Employees: 9

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

0.86% less ownership

Funds ownership: 16.38% [Q1] → 15.52% (-0.86%) [Q2]

33% less funds holding

Funds holding: 24 [Q1] → 16 (-8) [Q2]

60% less capital invested

Capital invested by funds: $1.21M [Q1] → $481K (-$729K) [Q2]

80% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 10

82% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 11

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $1.50 5% downside
• Avg. target: $1.50 5% downside
• High target: $1.50 5% downside

1 analyst rating

• positive: 0 0%
• neutral: 1 100%
• negative: 0 0%

HC Wainwright & Co. Swayampakula Ramakanth

5% downside $1.50

Neutral Reiterated

14 Aug 2025